BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35428894)

  • 21. Impact of COVID-19 Pandemic on Colorectal Cancer Screening Program.
    D'Ovidio V; Lucidi C; Bruno G; Lisi D; Miglioresi L; Bazuro ME
    Clin Colorectal Cancer; 2021 Mar; 20(1):e5-e11. PubMed ID: 32868231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impacts of COVID-19 on Appropriate Use of Screening Colonoscopy in a Large Integrated Healthcare Delivery System.
    Adams MA; Kerr EA; Gao Y; Saini SD
    J Gen Intern Med; 2023 Aug; 38(11):2577-2583. PubMed ID: 37231209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomes.
    Walshe M; Moran R; Boyle M; Cretu I; Galvin Z; Swan V; Trikovic J; Farrell MP; Foy S; O'Brien L; Leyden J; Mulligan N; Fenlon H; Gallagher DJ; MacMathúna P
    Cancer Epidemiol; 2017 Oct; 50(Pt A):30-38. PubMed ID: 28783501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The conversion factor for predicting adenoma detection rate from polyp detection rate varies according to colonoscopy indication and patient sex.
    Vojtechova G; Ngo O; Grega T; Kmochova K; Voska M; Buckova B; Majek O; Zavoral M; Suchanek S
    Eur J Cancer Prev; 2020 Jul; 29(4):294-302. PubMed ID: 32543806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colonoscopy: a review of its yield for cancers and adenomas by indication.
    Rex DK
    Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Influence of Face Shields on the Quality of Colonoscopy in the Era of the COVID-19 Pandemic.
    Lee JW; Lee HJ; Kim DS; Yoon J; Hong SW; Hwang HW; Lee JS; Kim GU; Lee S; Choe J; Park JH; Yang DH; Byeon JS
    Gut Liver; 2022 May; 16(3):404-413. PubMed ID: 34426561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the SARS-CoV-2 pandemic on colorectal cancer diagnosis and prognosis.
    Medina-Prado L; Sala-Miquel N; Aicart-Ramos M; López-Cardona J; Ponce-Romero M; Ortíz O; Pellisé M; Aguilera L; Díez-Redondo P; Núñez-Rodríguez H; Seoane A; Domper-Arnal MJ; Borao-Laguna C; González-Bernardo Ó; Suárez A; Muñoz-Tornero M; Bustamante-Balén M; Soutullo-Castiñeiras C; Balleste-Peris B; Esteban P; Jiménez-Gómez M; Albert M; Lucas J; Valdivieso-Cortázar E; López-Serrano A; Solano M; Tejedor-Tejada J; Trelles M; Zapater P; Jover R
    Cancer Med; 2024 Mar; 13(5):e6923. PubMed ID: 38491824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A direct comparison of the prevalence of advanced adenoma and cancer between surveillance and screening colonoscopies.
    Crispin A; Mansmann U; Munte A; Op den Winkel M; Göke B; Kolligs FT
    Digestion; 2013; 87(3):170-5. PubMed ID: 23635429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
    Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
    Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open Access Colonoscopy for Colorectal Cancer Prevention: An Evaluation of Appropriateness and Quality.
    Kapila N; Singh H; Kandragunta K; Castro FJ
    Dig Dis Sci; 2019 Oct; 64(10):2798-2805. PubMed ID: 30955174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colonoscopist Performance and Colorectal Cancer Risk After Adenoma Removal to Stratify Surveillance: Two Nationwide Observational Studies.
    Wieszczy P; Waldmann E; Løberg M; Regula J; Rupinski M; Bugajski M; Gray K; Kalager M; Ferlitsch M; Kaminski MF; Bretthauer M
    Gastroenterology; 2021 Mar; 160(4):1067-1074.e6. PubMed ID: 33065063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization and determinants of follow-up colonoscopies within 6 years after screening colonoscopy: Prospective cohort study.
    Hoffmeister M; Holleczek B; Stock C; Zwink N; Stolz T; Stegmaier C; Brenner H
    Int J Cancer; 2019 Jan; 144(2):402-410. PubMed ID: 30203838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation.
    Hijos-Mallada G; Alfaro E; Navarro M; Cañamares P; Ariño I; Charro M; Bruno C; Solano M; Pardillos A; Jimeno C; Carrera-Lasfuentes P; Lanas A; Domper-Arnal MJ
    Gastroenterol Hepatol; 2023 Nov; 46(9):702-709. PubMed ID: 36716926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
    Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
    Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis.
    Walker E; Fu Y; Sadowski DC; Stewart D; Tang P; Kaposhi B; Chappell H; Robson P; Veldhuyzen van Zanten S
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.
    Brenner H; Altenhofen L; Kretschmann J; Rösch T; Pox C; Stock C; Hoffmeister M
    Gastroenterology; 2015 Aug; 149(2):356-66.e1. PubMed ID: 25911510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenoma Detection Rate in Colonoscopy: Is Indication a Predictor?
    Yang PF; Wong SW
    Surg Laparosc Endosc Percutan Tech; 2016 Apr; 26(2):156-61. PubMed ID: 26813239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
    Loveday C; Sud A; Jones ME; Broggio J; Scott S; Gronthound F; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Williams M; Barry C; Riboli E; Kipps E; McFerran E; Muller DC; Lyratzopoulos G; Lawler M; Abulafi M; Houlston RS; Turnbull C
    Gut; 2021 Jun; 70(6):1053-1060. PubMed ID: 32855306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenoma and Sessile Serrated Lesion Detection Rates at Screening Colonoscopy for Ages 45-49 Years vs Older Ages Since the Introduction of New Colorectal Cancer Screening Guidelines.
    Ladabaum U; Shepard J; Mannalithara A
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2895-2904.e4. PubMed ID: 35580769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality indicators for screening colonoscopy and colonoscopist performance and the subsequent risk of interval colorectal cancer: a systematic review.
    Lund M; Trads M; Njor SH; Erichsen R; Andersen B
    JBI Database System Rev Implement Rep; 2019 Nov; 17(11):2265-2300. PubMed ID: 31188154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.